< Back to previous page
Researcher
Maarten Lambrecht
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Department of Oncology (Department)
Member
From1 Oct 2017 → 20 Dec 2018 - Laboratory of Experimental Radiotherapy (Division)
Member
From1 Oct 2010 → Today
Projects
1 - 10 of 11
- ProPOSE: Proton therapy in Pregnancy for Optimal, Safe and Effective cancer treatmentFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- To cure is to live: reducing cardiac impact of modern breast cancer radiotherapy.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Advanced brain imaging in radiation-induced changes after novel radiotherapy techniquesFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Towards cost-effective patient selection for proton therapy in thoracic cancers: a framework for continuously updating prediction modelsFrom1 Oct 2023 → TodayFunding: FWO Applied Biomedical Research (TBM)
- ProPOSE: Proton therapy in Pregnancy for Optimal, Safe and Effective cancer treatmentFrom1 Jan 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Implementation of AI-based contouring and treatment planning for daily personalized RT treatments for lung cancerFrom1 Jun 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Self-management of symptom clusters in (ex-) breast, prostate and lung cancer patients treated with radiotherapy: development of a care trajectory.From1 Jan 2022 → 31 Aug 2022Funding: Foundations, funds and other with scientific goal
- Neurocognition-sparing radiotherapy of brain and base of skull tumours: modelling toxicity and probing dose-dependent alterations in the brain using advanced imaging techniques.From18 Nov 2020 → TodayFunding: FWO Strategic Basic Research Grant
- Exploring strategies to reduce toxicity in the multimodal treatment of esophageal cancerFrom1 Jun 2017 → 31 May 2021Funding: Nonprofit institution or equivalents
- Exploring strategies to reduce toxicity in the multimodal treatment of oesophageal cancerFrom1 Aug 2016 → 9 Nov 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
31 - 40 of 105
- Treatment plan prediction for lung IMRT using deep learning based fluence map generation(2022)
Authors: Liesbeth Vandewinckele, Siri Willems, Maarten Lambrecht, Frederik Maes, Wouter Crijns
Pages: 44 - 54 - Coverage with evidence development: generating real-life evidence on SBRT in Belgium.(2022)
Authors: Maarten Lambrecht
Pages: S454 - S455 - Estimates of alpha/beta ratios for individual late urinary toxicity endpoints: analysis of a cohort trial(2022)
Authors: Maarten Lambrecht
Pages: S485 - S488 - Predicting patient-reported symptom clusters in lung cancer patients: a machine learning approach(2022)
Authors: Maarten Lambrecht
Pages: S111 - S112 - Development and Optimization of a Machine- Learning Prediction Model for Acute Desquamation After Breast Radiation Therapy in the Multicenter REQUITE Cohort(2022)
Authors: Maarten Lambrecht
- Healthy tissue sparing in proton therapy of lung tumors using statistically sound robust planning(2022)
Authors: Vlad Mihai Badiu, Maarten Lambrecht, Edmond Sterpin
Pages: S1285 - S1286 - Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)(2022)
Authors: Gilles Defraene, Maarten Lambrecht
Pages: 228 - 241 - Improved healthy tissue sparing in proton therapy of lung tumors using statistically sound robust optimization and evaluation(2022)
Authors: Vlad Mihai Badiu, Maarten Lambrecht, Edmond Sterpin
Pages: 62 - 69 - The European Particle Therapy Network (EPTN) consensus on the follow-up of adult patients with brain and skull base tumours treated with photon or proton irradiation(2022)
Authors: Laurien De Roeck, Maarten Lambrecht
Pages: 241 - 249 - Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer(2022)
Authors: Maarten Lambrecht
Pages: 75 - 82